Jaguar Health Future Growth

Future criteria checks 2/6

Jaguar Health is forecast to grow earnings and revenue by 25.6% and 41.8% per annum respectively while EPS is expected to grow by 147.4% per annum.

Key information

25.6%

Earnings growth rate

147.4%

EPS growth rate

Pharmaceuticals earnings growth17.9%
Revenue growth rate41.8%
Future return on equityn/a
Analyst coverage

Low

Last updated19 Jul 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:1JA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202519-24N/A-121
12/31/202413-30N/A-201
6/30/202410-36-29-29N/A
3/31/202410-38-30-30N/A
12/31/202310-41-33-33N/A
9/30/202311-40-33-32N/A
6/30/202311-44-34-34N/A
3/31/202311-42-37-35N/A
12/31/202212-47-35-33N/A
9/30/202211-54-37-36N/A
6/30/20228-54-38-37N/A
3/31/20226-59-36-36N/A
12/31/20214-53-35-35N/A
9/30/20215-50-30-30N/A
6/30/20217-46-24-24N/A
3/31/202110-42-18-18N/A
12/31/20209-39-15-15N/A
9/30/20208-35-14-14N/A
6/30/20207-39-20-20N/A
3/31/20205-45-21-21N/A
12/31/20196-45-20-20N/A
9/30/20196-48-22-22N/A
6/30/20196-43-16-16N/A
3/31/20195-34-17-17N/A
12/31/20184-32-23-23N/A
9/30/20184-41-23-23N/A
6/30/20184-30-23-23N/A
3/31/20184-24N/A-19N/A
12/31/20174-22N/A-10N/A
9/30/20173-5N/A-7N/A
6/30/20172-14N/A-17N/A
3/31/20171-17N/A-15N/A
12/31/20160-15N/A-14N/A
12/31/201505N/A1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1JA is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 1JA is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 1JA is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 1JA's revenue (41.8% per year) is forecast to grow faster than the German market (5.3% per year).

High Growth Revenue: 1JA's revenue (41.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 1JA's Return on Equity is forecast to be high in 3 years time


Discover growth companies